This information is intended for patients prescribed apixaban in Ireland only

Welcome to patients who have been prescribed apixaban

Please select one of the options below to access information relevant to you:
Atrial Fibrillation

I have non-valvular atrial fibrillation and have been prescribed apixaban to reduce my risk of stroke

READ MORE
DVT or PE

I have been prescribed apixaban to treat either deep vein thrombosis (DVT) or pulmonary embolism (PE), or to prevent them from recurring

READ MORE
Following Surgery

I have been prescribed apixaban following hip or knee replacement surgery to prevent formation of blood clots

READ MORE

Patients prescribed apixaban

This section is intended for patients prescribed apixaban in Ireland to provide information on this medicine, and its uses. It is not intended to replace in any way the opinion of a healthcare professional. For specific information about your condition and/or its detection, diagnosis, prognosis, administration and, where applicable, appropriate treatment for each specific case, please promptly consult a healthcare professional. The use of this website is subject to the legal notice, the privacy and cookie policy, the pharmacovigilance notice (if appropriate) and the applicable laws and regulations.

Report Side Effects

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

You can also report side effects directly via Freepost, HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517; Website: www.hpra.ie; E-mail: medsafety@hpra.ie.

By reporting side effects you can help provide more information on the safety of this medicine.

Adverse reactions should also be reported to Bristol-Myers Squibb Medical Information on 1 800 749 749 or medical.information@bms.com.

© 2015 Bristol-Myers Squibb Pharmaceuticals Limited

All corporate names and logos of BMS and/or of its products are trademarks of Bristol-Myers Squibb Company and are protected by national and international intellectual and industrial property laws. All rights reserved over the content of this website.

Pharmacovigilance Notice: This website has not been designed and must not be used to collect or provide safety information related to Bristol-Myers Squibb products. If your query relates to an adverse event experienced by a patient, please contact the Pharmacovigilance Department on 1 800 749 749 (Ireland only freephone number) or +44 1895 523740 (international number) which is available 24 hours a day, 365 days a year, or contact us by email at medical.information@bms.com.

Your use of this website is subject to the Legal Notice, the Privacy and Cookie Policy, the Pharmacovigilance Notice and the applicable laws and regulations.

432IE1500021-10 / ELI/2015/010/1
Date of approval: September 2015